NCT05031871

Pharmacokinetics of HR17031 Injection in Healthy Subjects

Pharmacokinetic Study of HR17031 Injection in Healthy Subjects (Single-center, Randomized, Open-label, 4 Cycles, 4 Sequences)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

To compare the pharmacokinetics and safety of HR17031 injection, SHR20004 injection and/or INS068 injection in healthy subjects

Conditions

• Type 2 Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	HR17031 injection ；INS068 injection；SHR20004 injection	HR17031 injection dose+INS068 injection dose+SHR20004 injection dose+(INS068+SHR20004) injection dose
DRUG	HR17031 injection ；INS068 injection；SHR20004 injection	INS068 injection dose+(INS068+SHR20004)injection dose+ HR17031 injection dose +SHR20004 injection dose
DRUG	HR17031 injection ；INS068 injection；SHR20004 injection	SHR20004 injection dose+ HR17031 injection dose +(INS 068+SHR20004) injection dose+ INS068 injection dose
DRUG	HR17031 injection ；INS068 injection；SHR20004 injection	(INS 068+SHR20004) injection dose+ SHR20004 injection dose+ INS068 injection dose+ HR17031 injection dose

Timeline

• Start date: 2021-09-02
• Primary completion: 2021-11-19
• Completion: 2021-11-19
• First posted: 2021-09-02
• Last updated: 2022-10-13

Locations

1 site across 1 country: China